Breakthroughs in Protein Misfolding: How 2026 Therapeutics are Reshaping the Global Neurodegenerative Disease Market Analysis and Patient Care
The dawn of 2026 has ushered in a transformative era for neurology, focusing heavily on the biological markers of cognitive decline. For decades, the medical community struggled to move beyond symptomatic relief for conditions like Alzheimer’s and Parkinson’s. However, recent advancements in monoclonal antibodies have allowed clinicians to target amyloid-beta plaques with...
0 Commentarii 0 Distribuiri 74 Views 0 previzualizare